Joseph Pitts actually said...

"Five years ago, the committee passed the reauthorization of the medical device user fee, and when we voted for that bill, we did so expecting that FDA would meet its end of the deal."

"Our medical innovation system is in jeopardy. Investment in life science area is declining at an alarming rate because of the escalating cost, time and risk of developing new drugs and devices."

"Frankly, we don't have 20 years or even 6 months to wait for FDA to fix the problems."

"We worry about the jurisdictional creep that has been going on where you seek to grab as much regulatory territory as possible."